Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis
The article presents a clinical observation of a patient with severe psoriasis and psoriatic arthritis. Due to insufficient efficacy of systemic therapy of psoriasis biologic disease-modifying therapy was started, but it was associated with difficulties. Development of erythrodermic form of psoriasi...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2019-03-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2682 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849240360383938560 |
|---|---|
| author | I. M. Marusenko N. N. Vezikova S. N. Kondrichin N. D. Silvestrov |
| author_facet | I. M. Marusenko N. N. Vezikova S. N. Kondrichin N. D. Silvestrov |
| author_sort | I. M. Marusenko |
| collection | DOAJ |
| description | The article presents a clinical observation of a patient with severe psoriasis and psoriatic arthritis. Due to insufficient efficacy of systemic therapy of psoriasis biologic disease-modifying therapy was started, but it was associated with difficulties. Development of erythrodermic form of psoriasis was observed during treatment with infliximab and abatacept was successfully used though it is not registered inRussiafor the treatment of psoriasis. |
| format | Article |
| id | doaj-art-241c8bb7f66b47efb4144a3658a2b306 |
| institution | Kabale University |
| issn | 1995-4484 1995-4492 |
| language | Russian |
| publishDate | 2019-03-01 |
| publisher | IMA PRESS LLC |
| record_format | Article |
| series | Научно-практическая ревматология |
| spelling | doaj-art-241c8bb7f66b47efb4144a3658a2b3062025-08-20T04:00:38ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922019-03-0157111111510.14412/1995-4484-2019-111-1152457Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritisI. M. Marusenko0N. N. Vezikova1S. N. Kondrichin2N. D. Silvestrov3Petrozavodsk State University, Medical Institute, Department of Hospital TherapyPetrozavodsk State University, Medical Institute, Department of Hospital TherapyPetrozavodsk State University, Medical Institute, Department of Hospital TherapyV.A. Baranov Republican HospitalThe article presents a clinical observation of a patient with severe psoriasis and psoriatic arthritis. Due to insufficient efficacy of systemic therapy of psoriasis biologic disease-modifying therapy was started, but it was associated with difficulties. Development of erythrodermic form of psoriasis was observed during treatment with infliximab and abatacept was successfully used though it is not registered inRussiafor the treatment of psoriasis.https://rsp.mediar-press.net/rsp/article/view/2682psoriasispsoriatic arthritismethotrexateinfliximababataceptustekinumab |
| spellingShingle | I. M. Marusenko N. N. Vezikova S. N. Kondrichin N. D. Silvestrov Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis Научно-практическая ревматология psoriasis psoriatic arthritis methotrexate infliximab abatacept ustekinumab |
| title | Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis |
| title_full | Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis |
| title_fullStr | Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis |
| title_full_unstemmed | Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis |
| title_short | Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis |
| title_sort | difficulties in choosing a biologic disease modifying anti rheumatic drug for the treatment of psoriasis and psoriatic arthritis |
| topic | psoriasis psoriatic arthritis methotrexate infliximab abatacept ustekinumab |
| url | https://rsp.mediar-press.net/rsp/article/view/2682 |
| work_keys_str_mv | AT immarusenko difficultiesinchoosingabiologicdiseasemodifyingantirheumaticdrugforthetreatmentofpsoriasisandpsoriaticarthritis AT nnvezikova difficultiesinchoosingabiologicdiseasemodifyingantirheumaticdrugforthetreatmentofpsoriasisandpsoriaticarthritis AT snkondrichin difficultiesinchoosingabiologicdiseasemodifyingantirheumaticdrugforthetreatmentofpsoriasisandpsoriaticarthritis AT ndsilvestrov difficultiesinchoosingabiologicdiseasemodifyingantirheumaticdrugforthetreatmentofpsoriasisandpsoriaticarthritis |